Skip to main content

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award

Agency: National Institutes of Health

Assistance Listings
  • 93.350 -- National Center for Advancing Translational Sciences

Forecasted opportunityLast Updated: Jul 20, 2026

Important dates

  • Forecasted post date: September 1, 2026
  • Forecasted application due date: February 16, 2027
  • Forecasted award date: December 15, 2027
  • Forecasted project start date: December 15, 2027
  • Fiscal Year: 2028

Award details

  • Expected project funding: Not specified
  • Expected awards: Not specified

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:PAR-28-008
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: July 20, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The purpose of the Congressionally mandated Clinical and Translational Science Award (CTSA) Program is to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions that improve patient and public health by funding and coordinating a national network of academic medical centers that provide the infrastructure, expertise, training, and collaboration needed to move discoveries from the laboratory into clinical practice and community health. The purpose of the reissuance of the Collaborative and Innovative Acceleration Award for the CTSA Program Notice of Funding Opportunity (NOFO) is to support the collaborative development of innovative approaches, technologies, or models that synergistically enhance the impact of research, advance translational science, and bring more treatments for all people more quickly. 

Eligibility

Miscellaneous

  • Other

Additional information on eligibility

Eligibility for this NOFO is limited to recipients that have successfully competed for an award under the Clinical and Translational Science Awards (CTSA) UM1 NOFO PAR-24-272 or subsequent iterations, as either a prime recipient or as a partnering institution.

Documents

No documents are currently available.

Agency contact information

Email: ctsa_collaborativeinnovation@mail.nih.gov

ctsa_collaborativeinnovation@mail.nih.gov

Division of Clinical Innovation, NCATS Please contact via e-mail.

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov